ArticleFrontiers in immunology2021

Case Report: Sustained Remission Due to PD-1-Inhibition in a Metastatic Melanoma Patient With Depleted B Cells.

Lena Margarethe Wulfken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.